Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 7/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.38 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL491250 | 0.97 | MEN1 (0.42) | MEN1MAPTKMT2AALDH1A1MAPK1 | |
| SCHEMBL1415320 | 0.85 | ESR1 (0.38) | MAPTALOX15TDP1CYP3A4HTT | |
| SCHEMBL5695686 | 0.82 | TYR (0.46) | ALDH1A1MAPK1TP53HIF1AHTT | |
| SCHEMBL5955 | 0.79 | MAPT (0.53) | MEN1MAPTKMT2AALDH1A1MAPK1 | |
| SCHEMBL3482829 | 0.77 | ESR1 (0.52) | MEN1MAPTKMT2AALDH1A1MAPK1 | |
| SCHEMBL9510147 | 0.77 | PTGS2 (0.39) | CYP3A4TP53NPC1RAB9A | |
| Water SCHEMBL4672027 | 0.77 | MAPT (0.50) | MEN1MAPTKMT2AALDH1A1MAPK1 | |
| Ammonia Solution, Strong SCHEMBL28370828 | 0.77 | MAPT (0.50) | MEN1MAPTKMT2AALDH1A1MAPK1 | |
| SCHEMBL8164161 | 0.77 | ESR1 (0.52) | MEN1MAPTKMT2AALDH1A1MAPK1 | |
| SCHEMBL7518483 | 0.77 | MEN1 (0.50) | MEN1MAPTKMT2AALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10751896-B2 | Shaving article with surface modification | THE GILLETTE COMPANY LLC (US) | 2020-08-25 | — | — | US | disclosed |
| US-9758506-B2 | Muscarinic agonists | HEPTARES THERAPEUTICS LIMITED (GB) | 2017-09-12 | — | — | US | disclosed |
| US-9758506-B2 | Muscarinic agonists | HEPTARES THERAPEUTICS LIMITED (GB) | 2017-09-12 | — | — | US | disclosed |
| US-20170037025-A1 | Muscarinic Agonists | NXERA PHARMA UK LIMITED (GB) | 2017-02-09 | — | — | US | disclosed |
| US-20170037025-A1 | Muscarinic Agonists | NXERA PHARMA UK LIMITED (GB) | 2017-02-09 | — | — | US | disclosed |
| EP-2326645-B9 | COMPOUND WITH SEROTONINERGIC ACTIVITY, PROCESS FOR PREPARING IT AND PHARMACEUTICAL COMPOSITION COMPRISING IT | ACRAF (IT) | 2013-04-17 | — | — | EP | disclosed |
| CN-101233117-B | Multidentate aza ligands capable of complexing metal ions and their use in diagnostics and therapeutics | BRACCO IMAGING SPA | 2013-03-27 | — | — | CN | disclosed |
| US-8361908-B2 | Modified surface material, method for preparing same and uses thereof | UNIVERSITE PARIS 7-DENIS DIDEROT (FR) | 2013-01-29 | — | — | US | disclosed |
| US-8361908-B2 | Modified surface material, method for preparing same and uses thereof | UNIVERSITE PARIS 7-DENIS DIDEROT (FR) | 2013-01-29 | — | — | US | disclosed |
| EP-2326645-B1 | COMPOUND WITH SEROTONINERGIC ACTIVITY, PROCESS FOR PREPARING IT AND PHARMACEUTICAL COMPOSITION COMPRISING IT | ACRAF (IT) | 2012-11-07 | — | — | EP | disclosed |
| US-20060167199-A1 | Process for produciton of living radical polymers and polymers | OTSUKA CHEMICAL CO., LTD. (JP) | 2006-07-27 | — | — | US | disclosed |
| US-20060135711-A1 | Process for the production of living radical polymers and polymers | OTSUKA CHEMICAL CO., LTD. (JP) | 2006-06-22 | — | — | US | disclosed |
| CN-1780860-A | Method for producing living radical polymer and polymer | OTSUKA CHEMICAL CO LTD (JP) | 2006-05-31 | — | — | CN | disclosed |
| EP-1619211-A1 | PROCESS FOR PRODUCTION OF LIVING-RADICAL POLYMERS AND POLYMERS | OTSUKA CHEMICAL COMPANY, LIMITED (JP) | 2006-01-25 | — | — | EP | disclosed |
| EP-1595894-A1 | PROCESS FOR THE PRODUCTION OF LIVING RADICAL POLYMERS AND POLYMERS | OTSUKA CHEMICAL COMPANY, LIMITED (JP) | 2005-11-16 | — | — | EP | disclosed |
| US-20050245714-A1 | Organic tellurium compound, process for producing the same, living radical polymerization initiator, process for producing polymer with the same, and polymer | OTSUKA CHEMICAL CO., LTD. (JP) | 2005-11-03 | — | — | US | disclosed |
| CN-1675253-A | Method for producing living radical polymer and polymer | OTSUKA CHEMICAL CO LTD (JP) | 2005-09-28 | — | — | CN | disclosed |
| CN-1649838-A | Organic tellurium compound, method for producing same, living radical polymerization initiator, method for producing polymer using same, and polymer | OTSUKA KAGAKU KK (JP) | 2005-08-03 | — | — | CN | disclosed |
| EP-1541550-A1 | ORGANIC TELLURIUM COMPOUND, PROCESS FOR PRODUCING THE SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER WITH THE SAME, AND POLYMER | Otsuka Chemical Co., Ltd. (JP) | 2005-06-15 | — | — | EP | disclosed |
| EP-1541592-A1 | PROCESS FOR PRODUCTION OF LIVING RADICAL POLYMERS AND POLYMERS | OTSUKA CHEMICAL COMPANY, LIMITED (JP) | 2005-06-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050245714-A1 | Organic tellurium compound, process for producing the same, living radical polymerization initiator, process for producing polymer with the same, and polymer | ODC1, TERB1, TTI1 | MEN1 806/4885MAPT 1588/4885KMT2A 769/4885 |
| US-20060135711-A1 | Process for the production of living radical polymers and polymers | CBR3, CBR1, CCNT1 | MEN1 1560/4885MAPT 2999/4885KMT2A 1033/4885 |
| US-20170037025-A1 | Muscarinic Agonists | CHRM1, CHRM2, CHRM3 | MEN1 592/4885MAPT 2144/4885KMT2A 1818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.